PFE
9:00 AM
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
Trial Results • Phase 2pfizer.com
News Updates
Sat, Jun 6, 2026
1 updatesSat, May 30, 2026
1 updatesPFE
8:00 AM
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
Trial Results • Phase 3pfizer.com
Tue, Mar 17, 2026
1 updatesPFE
6:45 AM